Related content

Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication

By Ma Yanlei  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1089-1095

Humana Press, Inc

Access to resources Recommend Favorite

Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapynaive advanced non-small cell lung cancer

By          

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1699-1703

Spandidos Publications

Access to resources Recommend Favorite

Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer

By Park Keon   Ahn Jin   Park Young   Lee Jeeyun   Kang Jung   Park Joon   Lim Ho   Im Young-Hyuck   Kang Won   Park Keunchil   Lee Soon  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 1, 2007-01 ,pp. : 17-21

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II Study of Paclitaxel in Advanced Breast Cancer Resistant to Anthracyclines

By Fountzilas G.   Athanassiades A.   Giannakakis T.   Bafaloukos D.   Karakousis K.   Dombros N.   Kosmidis P.   Skarlos D.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite

Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer

By Espinosa E.   Morales S.   Borrega P.   Casas A.   Madroñal C.   Machengs I.   Illarramendi J.   Lizón J.   Moreno J.   Belón J.   Janáriz J.   Puente M.   Checa T.   Mel J.   González Barón M.  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 6, 2004-12 ,pp. : 546-552

Springer Publishing Company

Access to resources Recommend Favorite